ライフサイエンスコーパス: cisatracurium

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ng partial neuromuscular blockade (PNB; i.v. cisatracurium).

2 patches by (+)-tubocurarine, pancuronium and cisatracurium.

3 of (+)-tubocurarine and pancuronium but not cisatracurium.

4 ic, 34 +/- 6/s; adult: 13 +/- 5/s) rates for cisatracurium.

5 urium-exposed patients with a negative ST to cisatracurium.

6 inverse ratio ventilation and paralyzed with cisatracurium.

7 imes to 70% recovery of Train-of-Four ratio (cisatracurium 60 mins, atracurium 57 mins), although the

8 Here, we examine cisatracurium, a commonly used muscle relaxant.

9 Cisatracurium, an isomer of atracurium, appears to be a

10 The situation was similar for cisatracurium and (+)-tubocurarine or metocurine.

11 Outside-out patches were equilibrated with cisatracurium before application of 300 microM acetylcho

12 ficial binding site for the large antagonist cisatracurium compared to the other ligands, or from a c

13 Cisatracurium did not shift the apparent IC(50) of pancu

14 One patient who received cisatracurium exhibited intermittent bronchospasm during

15 urium-sensitized patient and negative in all cisatracurium-exposed patients with a negative ST to cis

16 a rapid perfusion system to apply or remove cisatracurium for various times before application of ac

17 e measurements correspond to dissociation of cisatracurium from receptors in the absence of acetylcho

18 Cisatracurium infusion rates ranged from 6.3 to 10.5 mic

19 cisatracurium inhibited the initial peak current, but th

20 )-tubocurarine and pancuronium compared with cisatracurium is notable.

21 Forty patients received cisatracurium (mean duration 48.1 +/- 4.2 [SEM] hrs), an

22 us doses followed by continuous infusions of cisatracurium or atracurium were administered.

23 20 (9-29), 21 (4-36), and 1.5 (0.3-2.9) for cisatracurium, pancuronium, vecuronium, and rocuronium,

24 vity for four other competitive antagonists: cisatracurium, pancuronium, vecuronium, and rocuronium.

25 BAT atracurium was positive in one cisatracurium-sensitized patient and negative in all cis

26 in protocol I (FI) matched closely the post-cisatracurium smooth-muscle pressure profile in protocol

27 non-oesophageal pathology were administered cisatracurium to paralyse the crus.

28 - 6, 106 +/- 8 and 116 +/- 10 kJ mol(-1) for cisatracurium, (+)-tubocurarine and pancuronium, respect

29 interpatient variation (20 to 175 mins with cisatracurium vs. 35 to 85 mins with atracurium).

30 The infusion rate for patients receiving cisatracurium was 3.1 +/- 0.2 microg/kg/min, and for pat

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。